About US
Contact us
-
AstraZeneca COVID-19 shot tagged with new warning in EU, highlighting rare blood clot riskEurope’s drug regulator has been probingcasesof rare blood clots in AstraZeneca COVID-19 vaccine recipients since mid-March—and now it has confirmed a possible link. The agency stressed that the bene2021/4/7
-
BeiGene's massive biologics plant in China wins first commercial manufacturing nodBeiGene is taking over manufacturingforits China-approved PD-1 checkpoint inhibitorthanks to a new approval for a massive biologics factory. The China National Medical Products Administration (NMPA)2021/4/6
-
Nitto Denko lays out $226M to boost oligonucleotide production in a bustling RNA marketWith oligonucleotides on the rise totreat rare diseases and cancers, Japanese manufacturerNitto Denko is laying big plans. Nitto will plug a whopping25 billion yen ($225.93 million) into its Massachu2021/4/2
-
AstraZeneca's COVID vaccine faces new round of restrictions—even after the EMA's renewed backingSeveral countries stopped using AstraZeneca's COVID-19 shot earlier this month after reports of rare blood clots following vaccination.The European Medicines Agency sought to add clarity to the issue2021/4/2
-
Up to 15M Johnson & Johnson coronavirus vaccine doses ruined due to human error: NYTJohnson & Johnson's COVID-19 vaccine rollout has beenslower than expected in the U.S., with just 6.8 million dosesdeliveredto states in the first month.Now, The New York Times has revealed behind2021/3/30
-
Apotex yanks ADHD med after traces of schizophrenia drug turn up in a single lotWhen traces of the wrong drug appearin a tablet, it's best to err on the side of caution. Apotex did just that Wednesday, when it said it would pullseveralbatches of an attention deficit hyperactivit2021/3/30
-
IRS alleges Bristol Myers dodged $1.38B in taxes with offshore patent scheme: reportWall Street analyst Tim Anderson is known for asking tough questions during pharma companies’ earnings calls, so it may not have seemed surprising when he brought up Bristol Myers Squibb’s massive dr2021/3/29
-
Pharma Pfizer, BioNTech eye full FDA approval for COVID-19 vaccine as efficacy stands strong, including against aggressive variantPfizer and BioNTech offered an updated look at the efficacy of their COVID-19 vaccine, BNT162b2. The overall efficacy figure remained high at 91.3%, and the shot showed it can protect against a notor2021/3/29
-
AbbVie says biosim maker Alvotech recruited a manufacturing exec to steal trade secrets on HumiraAs AbbVie braces for biosimilar competition to its top drug Humira, the company is takingbiosimsmakerAlvotech to taskin court over alleged trade secrets theft. In a newlawsuitfiled in Illinois, AbbVi2021/3/25
-
GSK cuts ties with Slaoui over sexual harassment allegations as CEO Walmsley vows to rename R&D siteMoncef Slaoui, Ph.D., attracted both acclaim and controversy during his time as co-leader of the U.S. government’s Operation Warp Speed effort to speed COVID-19 vaccines to market. Now, he’s facing s2021/3/25